Denise Fulton - Profile and Journalist Details
Find journalists that align with your industry, location and vision. Unlock Denise Fulton's full journalist profile, including location, coverage topics, current employer, biography and preferences. Sign up today and start building journalist relationships that fuel your startup's growth.
Get connected with journalists today
Denise Fulton
Verified
Vice President, Research and Content Strategy, Regulatory Focus
Rockville
Beats
Politics, conflict
Content
Recon: US Supreme Court to take up Amgen patent case; Monoclonal antibody for RSV gets EMA approval | RAPS
By Denise Fulton| Regulatory Affairs Professionals Society@ Recon: US Supreme Court to take up Amgen patent case; Monoclonal antibody for RSV gets EMA approval Recon | 07 November 2022 | By Denise Fulton Welcome to Regulatory Reconnaissance, your daily regulatory news and intelligence briefing.
By Denise Fulton| Regulatory Focus Verified Posted 02 November 2020 | By Denise Fulton Lessons learned from early COVID-19 emergency use authorizations (EUAs) granted by the US Food and Drug Administration (FDA) could go far to improve public trust in a future EUA or approval of a vaccine – and in the regulatory process itself, Herschel Nachlis writes in the Health Affairs Blog.
Recon: US Supreme Court to take up Amgen patent case; Monoclonal antibody for RSV gets EMA approval | RAPS
By Denise Fulton| Regulatory Affairs Professionals Society@ Recon: US Supreme Court to take up Amgen patent case; Monoclonal antibody for RSV gets EMA approval Recon | 07 November 2022 | By Denise Fulton Welcome to Regulatory Reconnaissance, your daily regulatory news and intelligence briefing.
Company Info
Regulatory Focus
Rockville, Maryland, United States
+1 301-770-2920